Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

3703 Press Releases
DateTitleCompany
03 Sep 15 Ocata Therapeutics Receives SBIR Grant from the NIH’s National Eye Institute to Develop Proprietary Photoreceptor Progenitor Cell Therapy for Retinitis Pigmentosa Ocata Therapeutics,
Published by
PharmiWeb.com
03 Sep 15 Ocata Therapeutics Appoints Dr. Brian Levy to its Board of Directors Ocata Therapeutics,
Published by
PharmiWeb.com
03 Sep 15 Probiodrug to present at European Life Sciences Conferences Probiodrug,
Published by
PharmiWeb.com
03 Sep 15 Probiodrug Licenses the TBA 2.1 Transgenic Alzheimer’s Disease Mouse Model to QPS Austria Neuropharmacology Probiodrug,
Published by
PharmiWeb.com
03 Sep 15 Sartorius Stedim Biotech and GE Healthcare sign worldwide OEM supply agreement Sartorius Stedim Biotech,
Published by
PharmiWeb.com
03 Sep 15 Mobidiag and Unilabs Enter into Agreement over Use of Amplidiag Product Line for Molecular Gastrointestinal Diagnostics Mobidiag,
Published by
PharmiWeb.com
03 Sep 15 Allied Minds Names Joseph Pignato as Chief Financial Officer Allied Minds,
Published by
PharmiWeb.com
03 Sep 15 RF Biocidics Partners With Mexico-Based Food Company Sesajal Allied Minds,
Published by
PharmiWeb.com
03 Sep 15 Premune Broadens Portfolio With Novel Innovet Skin Health Product The Ruth Group,
Published by
PharmiWeb.com
03 Sep 15 Nektar Announces Receipt of $40 Million Milestone Payment Resulting from First Commercial Sale of MOVENTIG® (naloxegol) Tablets in Major European Market Nektar,
Published by
PharmiWeb.com
03 Sep 15 ESC launches new concept for driving innovation in cardiovascular research with exclusive support from Boehringer Ingelheim Boehringer Ingelheim,
Published by
PharmiWeb.com
03 Sep 15 Boehringer Ingelheim licenses Vectron Biosolutions’ expression technology platform Boehringer Ingelheim,
Published by
PharmiWeb.com
03 Sep 15 RCT Demonstrates a Hundred-fold Improvement in Penetration of Solid Tumors Using Therapeutic ABDURINS Compared to Antibodies. RCT,
Published by
PharmiWeb.com
03 Sep 15 MATRIX Trial Results Presented at Hot Line Session of ESC Congress 2015 and Simultaneously Published in The New England Journal of Medicine The Medicines Company,
Published by
PharmiWeb.com
03 Sep 15 Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing PCI via the Radial Approach The Medicines Company,
Published by
PharmiWeb.com
03 Sep 15 Key Protein Scientists Report Unique Benefits of the PCT Platform in the Analysis of Critical Samples, Such as Cancer Tissue Biopsies and Stem Cells Key Protein Scientists,
Published by
PharmiWeb.com
03 Sep 15 First patient recruited in PQ Birch dose study Allergy Therapeutics,
Published by
PharmiWeb.com
03 Sep 15 Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax KGI,
Published by
PharmiWeb.com
03 Sep 15 American Journal of Kidney Disease Publication Confirms Significant Patient Advantages with HHD versus PD American Journal of Kidney Disease,
Published by
PharmiWeb.com
03 Sep 15 ZIOPHARM to Present at the Wells Fargo 10th Annual Health Care Conference ZIOPHARM,
Published by
PharmiWeb.com
03 Sep 15 ZIOPHARM Announces Cancer Research Publication of Study Demonstrating Preferential Targeting of Solid Tumor Cells by Modified CAR T Cells ZIOPHARM,
Published by
PharmiWeb.com
03 Sep 15 RedHill Biopharma Announces Last Patient Visit in the Phase I Study With YELIVA(TM) (ABC294640) for Advanced Solid Tumors RedHill Biopharma,
Published by
PharmiWeb.com
03 Sep 15 RedHill Biopharma to Present at the Rodman & Renshaw 17th Annual Global Investment Conference RedHill Biopharma,
Published by
PharmiWeb.com
03 Sep 15 Adaptimmune to Participate in the 22nd Annual BioCentury ‘NewsMakers in the Biotech Industry’ Conference Adaptimmune,
Published by
PharmiWeb.com
03 Sep 15 Adaptimmune Expands Trial Of T-Cell Therapy For Synovial Sarcoma And Achieves Clinical Milestones Adaptimmune,
Published by
PharmiWeb.com
03 Sep 15 Heat Biologics, Inc. to Present at the 17th Annual Global Investment Conference Heat Biologics,
Published by
PharmiWeb.com
03 Sep 15 XBiotech Advances Phase 1/2 Clinical Study of Novel True Human™ Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus XBiotech,
Published by
PharmiWeb.com
03 Sep 15 ESI BIO - A Division of BioTime, Inc. Launches New Research Technology Platform, VascuNet™ Pericyte Co-Culture Assay ESI BIO,
Published by
PharmiWeb.com
03 Sep 15 BioTime Chief Executive Officer Dr. Michael D. West to be Keynote Speaker at Stem Cells & Regenerative Medicine Congress 2015 BioTime,
Published by
PharmiWeb.com
03 Sep 15 BioTime Subsidiary Asterias Therapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury Asterias Biotherapeutics,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.